Overview:

Medical Affairs is evolving faster than ever. Advances in artificial intelligence, increasing demands for strategic scientific engagement, growing pressure to demonstrate value, and rapidly shifting organizational structures are transforming how Medical Affairs teams operate. This webinar explores the innovations redefining the function today, from practical AI deployment in Medical Affairs activities to the emergence of Experienced Fractional Medical Affairs (EFMA) models that provide organizations with flexible, senior-level expertise exactly when it is needed most. Attendees will gain practical insights into how forward-looking organizations are modernizing Medical Affairs to improve efficiency, strengthen scientific leadership, and remain agile in uncertain market environments.

This webinar covers:

•  Real-world examples of how AI is being used in Medical Affairs today

•  AI applications for insight generation, literature review, scientific content support, and operational efficiency

•  How Medical Affairs organizations are adapting to economic and regulatory uncertainty

•  Key trends shaping the future Medical Affairs organization

•  Why flexibility and scalable expertise are becoming critical strategic advantages

•  The rise of Experienced Fractional Medical Affairs (EFMA) as a modern operating model

•  Case studies demonstrating how EFMA supports launch readiness, capability gaps, strategic leadership, and transition periods

 Who should attend:

•  Vice Presidents and Heads of Medical Affairs

•  Executive Medical Directors and Senior Medical Leaders

•  Emerging Biotech Founders and Start-Up Leaders

•  Commercial Strategy Leaders

•  Medical Operations Professionals

•  Life Sciences Innovation and Transformation Teams

Advantages of attending a boutique presentation:

•  More time to ask questions

•  Find resolutions to your problems

Presenter profile:

Michelle Chernock, PhD is the CEO of Leaders in Medical Affairs (LMA), a strategic consulting organization supporting pharmaceutical, biotechnology, and medical device companies through innovative Medical Affairs solutions. She is the creator of the Experienced Fractional Medical Affairs (EFMA) model, designed to provide organizations with scalable access to highly experienced Medical Affairs leadership. Michelle works extensively with industry leaders on Medical Affairs transformation, organizational strategy, stakeholder engagement, and emerging AI applications within the life sciences industry. She is also an active thought leader, speaker, and content creator focused on the future evolution of Medical Affairs.

Cancellation Policy:

  - 100% Refund: 

Requests must be submitted via email to contact@coepharma.com at least 10 business days (two weeks) before the scheduled webinar date. Please note that CoE Pharma does not refund fees paid to third-party processors (e.g., PayPal). 

  - No Refund: 

Cancellations made within 10 business days (two weeks) of the webinar date are not eligible for a refund.